Making Sense of the Epigenome Using Data Integration Approaches

dc.contributor.authorCazaly Emma
dc.contributor.authorSaad Joseph
dc.contributor.authorWang Wenyu Y.
dc.contributor.authorHeckman Caroline
dc.contributor.authorOllikainen Miina
dc.contributor.authorTang Jing
dc.contributor.organizationfi=tilastotiede|en=Statistics|
dc.contributor.organization-code2606103
dc.converis.publication-id39606957
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/39606957
dc.date.accessioned2022-10-28T13:50:16Z
dc.date.available2022-10-28T13:50:16Z
dc.description.abstractEpigenetic research involves examining the mitotically heritable processes that regulate gene expression, independent of changes in the DNA sequence. Recent technical advances such as whole-genome bisulfite sequencing and affordable epigenomic array-based technologies, allow researchers to measure epigenetic profiles of large cohorts at a genome-wide level, generating comprehensive high-dimensional datasets that may contain important information for disease development and treatment opportunities. The epigenomic profile for a certain disease is often a result of the complex interplay between multiple genetic and environmental factors, which poses an enormous challenge to visualize and interpret these data. Furthermore, due to the dynamic nature of the epigenome, it is critical to determine causal relationships from the many correlated associations. In this review we provide an overview of recent data analysis approaches to integrate various omics layers to understand epigenetic mechanisms of complex diseases, such as obesity and cancer. We discuss the following topics: (i) advantages and limitations of major epigenetic profiling techniques, (ii) resources for standardization, annotation and harmonization of epigenetic data, and (iii) statistical methods and machine learning methods for establishing data-driven hypotheses of key regulatory mechanisms. Finally, we discuss the future directions for data integration that shall facilitate the discovery of epigenetic-based biomarkers and therapies.
dc.identifier.jour-issn1663-9812
dc.identifier.olddbid184646
dc.identifier.oldhandle10024/167740
dc.identifier.urihttps://www.utupub.fi/handle/11111/51002
dc.identifier.urlhttps://www.frontiersin.org/articles/10.3389/fphar.2019.00126/full
dc.identifier.urnURN:NBN:fi-fe2021042823799
dc.language.isoen
dc.okm.affiliatedauthorTang, Jing
dc.okm.discipline112 Statistics and probabilityen_GB
dc.okm.discipline1184 Genetics, developmental biology, physiologyen_GB
dc.okm.discipline317 Pharmacyen_GB
dc.okm.discipline112 Tilastotiedefi_FI
dc.okm.discipline1184 Genetiikka, kehitysbiologia, fysiologiafi_FI
dc.okm.discipline317 Farmasiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherFRONTIERS MEDIA SA
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumberARTN 126
dc.relation.doi10.3389/fphar.2019.00126
dc.relation.ispartofjournalFrontiers in Pharmacology
dc.relation.volume10
dc.source.identifierhttps://www.utupub.fi/handle/10024/167740
dc.titleMaking Sense of the Epigenome Using Data Integration Approaches
dc.year.issued2019

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Cazaly_et_al_fphar-10-00126.pdf
Size:
620.95 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF